BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

C75

A [Supplementary Concept] competitive inhibitor of CPT I; structure in first source Heading Mapped to: Acyl Coenzyme A

49+ PubMed studies analyzed · Evidence Score: 36.1

Research Domains

C75 has been studied across 15 research domains including 🔥 Metabolic, ⚡ Energy & Fatigue, 🔬 Oncology, 🫁 Liver & Detox, 🧠 Focus & Attention. The primary research focus is 🔥 Metabolic with 37% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with C75, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Feprazone
2 shared targets
trichostatic
2 shared targets
Emetine
2 shared targets
Dactinomycin
2 shared targets
cycloheximide
2 shared targets
Calcimycin
2 shared targets
Daunorubicin
2 shared targets
Disulfiram
2 shared targets
hirudo
2 shared targets
scolopendra
2 shared targets
Loading evidence profile...

This evidence profile for C75 is generated deterministically from 49 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.